These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19714652)

  • 1. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis.
    Guo R; Zhou Q; Proulx ST; Wood R; Ji RC; Ritchlin CT; Pytowski B; Zhu Z; Wang YJ; Schwarz EM; Xing L
    Arthritis Rheum; 2009 Sep; 60(9):2666-76. PubMed ID: 19714652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice.
    Zhou Q; Guo R; Wood R; Boyce BF; Liang Q; Wang YJ; Schwarz EM; Xing L
    Arthritis Rheum; 2011 Aug; 63(8):2318-28. PubMed ID: 21538325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
    Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
    Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated Joint Tissue Damage Associated With Improved Synovial Lymphatic Function Following Treatment With Bortezomib in a Mouse Model of Experimental Posttraumatic Osteoarthritis.
    Wang W; Lin X; Xu H; Sun W; Bouta EM; Zuscik MJ; Chen D; Schwarz EM; Xing L
    Arthritis Rheumatol; 2019 Feb; 71(2):244-257. PubMed ID: 30144298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lymphangiogenesis in joints of mice with inflammatory arthritis.
    Zhang Q; Lu Y; Proulx ST; Guo R; Yao Z; Schwarz EM; Boyce BF; Xing L
    Arthritis Res Ther; 2007; 9(6):R118. PubMed ID: 17997858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.
    Huggenberger R; Ullmann S; Proulx ST; Pytowski B; Alitalo K; Detmar M
    J Exp Med; 2010 Sep; 207(10):2255-69. PubMed ID: 20837699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared lymphatic imaging demonstrates the dynamics of lymph flow and lymphangiogenesis during the acute versus chronic phases of arthritis in mice.
    Zhou Q; Wood R; Schwarz EM; Wang YJ; Xing L
    Arthritis Rheum; 2010 Jul; 62(7):1881-9. PubMed ID: 20309866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced lymphangiogenesis in cervical lymph nodes in oral melanoma-bearing mice.
    Ozasa R; Ohno J; Iwahashi T; Taniguchi K
    J Exp Clin Cancer Res; 2012 Oct; 31(1):83. PubMed ID: 23031500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow.
    Li J; Ju Y; Bouta EM; Xing L; Wood RW; Kuzin I; Bottaro A; Ritchlin CT; Schwarz EM
    Arthritis Rheum; 2013 Jan; 65(1):130-8. PubMed ID: 23002006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
    Mumprecht V; Honer M; Vigl B; Proulx ST; Trachsel E; Kaspar M; Banziger-Tobler NE; Schibli R; Neri D; Detmar M
    Cancer Res; 2010 Nov; 70(21):8842-51. PubMed ID: 20978206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI and quantification of draining lymph node function in inflammatory arthritis.
    Proulx ST; Kwok E; You Z; Beck CA; Shealy DJ; Ritchlin CT; Boyce BF; Xing L; Schwarz EM
    Ann N Y Acad Sci; 2007 Nov; 1117():106-23. PubMed ID: 17646265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
    Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
    J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Treatment of Tumor Necrosis Factor-Transgenic Mice With Anti-Tumor Necrosis Factor Restores Lymphatic Contractions, Repairs Lymphatic Vessels, and May Increase Monocyte/Macrophage Egress.
    Bouta EM; Kuzin I; de Mesy Bentley K; Wood RW; Rahimi H; Ji RC; Ritchlin CT; Bottaro A; Xing L; Schwarz EM
    Arthritis Rheumatol; 2017 Jun; 69(6):1187-1193. PubMed ID: 28118521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
    Lee JY; Hong SH; Shin M; Heo HR; Jang IH
    Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
    Iwami D; Brinkman CC; Bromberg JS
    Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and Lymphatic Function.
    Schwager S; Detmar M
    Front Immunol; 2019; 10():308. PubMed ID: 30863410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes.
    Halin C; Tobler NE; Vigl B; Brown LF; Detmar M
    Blood; 2007 Nov; 110(9):3158-67. PubMed ID: 17625067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.
    Goyal S; Chauhan SK; Dana R
    Arch Ophthalmol; 2012 Jan; 130(1):84-9. PubMed ID: 21911653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of lymphatics and lymph node-mediated immunity in choroidal neovascularization.
    Nakao S; Zandi S; Kohno R; Sun D; Nakama T; Ishikawa K; Yoshida S; Enaida H; Ishibashi T; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3830-6. PubMed ID: 23580489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
    Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
    J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.